NCT03189420 2024-04-19
Glioma Microenvironment an Exploratory Study
Hospital Sirio-Libanes
Active not recruiting
Clinical Trials
3 trialsNCT02751138 2023-05-16
Determination of Immune Phenotype in Glioblastoma Patients
University of Ulm
Completed
NCT00704808 2015-09-09
Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)
Merck Sharp & Dohme LLC
Completed